KalVista Pharmaceuticals (4XC1.STU) Q3 2026 Earnings

3SepConfirmed
Q4 2025
Q2 2026
Next
-0.8
-0.64
-0.48
-0.32

Details

Expected EPS
-0.32255912499999995
Actual EPS
N/A
Surprise EPS
0.32
Surprise Percent
+100%

Description

KalVista Pharmaceuticals (4XC1.STU) will report earnings of for Q3 2026 on September 03, 2026.

0 Comments

Share your thoughts